# VirnetX Holding Corp: overview VHC · Nasdaq · CIK 1082324 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/vhc.md) · [Financials](/companies/vhc/financials.md) · [Filings](/companies/vhc/filings.md) · [Insiders](/companies/vhc/insiders.md) Latest reported revenue: [$0](/filings/0001140361-26-033140.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001140361-26-033140). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [2.0](/filings/0001140361-25-042294.md) | [0.0 d](/filings/0001140361-26-010895.md) | [0.0](/filings/0001140361-26-021650.md) | [48.0](/filings/0001140361-26-033140.md) | [58.0](/filings/0001140361-25-042294.md) | [56.0 d](/filings/0001140361-26-010895.md) | [0.0](/filings/0001140361-26-021650.md) | [0.0](/filings/0001140361-26-033140.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(219350.0%)](/filings/0001140361-25-042294.md) | not reported | not reported | [(8216.7%)](/filings/0001140361-26-033140.md) | [(8006.9%)](/filings/0001140361-25-042294.md) | [(12151.8%) d](/filings/0001140361-26-010895.md) | not reported | not reported | | Net margin | % | [(191950.0%)](/filings/0001140361-25-042294.md) | not reported | not reported | [(7543.8%)](/filings/0001140361-26-033140.md) | [(7496.6%)](/filings/0001140361-25-042294.md) | [(11744.6%) d](/filings/0001140361-26-010895.md) | not reported | not reported | | Diluted EPS | $ per share | [(1.07)](/filings/0001140361-25-042294.md) | not reported | [(1.01)](/filings/0001140361-26-021650.md) | [(0.99)](/filings/0001140361-26-033140.md) | [(1.18)](/filings/0001140361-25-042294.md) | not reported | [(1.16)](/filings/0001140361-26-021650.md) | [(1.20)](/filings/0001140361-26-033140.md) | | Free cash flow | $k | [(3,221) d](/filings/0001140361-25-042294.md) | [(5,521) d](/filings/0001140361-26-010895.md) | not reported | not reported | [(3,021) d](/filings/0001140361-25-042294.md) | [(5,808) d](/filings/0001140361-26-010895.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.0](/filings/0001140361-23-015369.md) | [0.0](/filings/0001140361-24-013522.md) | [0.0](/filings/0001140361-25-009024.md) | [0.0](/filings/0001140361-26-010895.md) | [0.2](/filings/0001140361-26-010895.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(140497.1%)](/filings/0001140361-23-015369.md) | [(45991.7%)](/filings/0001140361-24-013522.md) | [(449214.3%)](/filings/0001140361-25-009024.md) | [(407940.0%)](/filings/0001140361-26-010895.md) | [(12000.0%)](/filings/0001140361-26-010895.md) | | Net margin | % | [(122631.4%)](/filings/0001140361-23-015369.md) | [(75541.7%)](/filings/0001140361-24-013522.md) | [(398157.1%)](/filings/0001140361-25-009024.md) | [(363500.0%)](/filings/0001140361-26-010895.md) | [(11250.0%)](/filings/0001140361-26-010895.md) | | Diluted EPS | $ per share | [(0.60)](/filings/0001140361-23-015369.md) | [(10.17)](/filings/0001140361-24-013522.md) | [(7.79)](/filings/0001140361-25-009024.md) | [(5.05)](/filings/0001140361-26-010895.md) | [(5.00)](/filings/0001140361-26-010895.md) | | Free cash flow | $m | [(51.7)](/filings/0001140361-23-015369.md) | [(16.9)](/filings/0001140361-24-013522.md) | [(24.8)](/filings/0001140361-25-009024.md) | [(15.3)](/filings/0001140361-26-010895.md) | [(15.7)](/filings/0001140361-26-010895.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/vhc/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.0m | 157,685 | | Added +2,144 | | [Williams Jones Wealth Management, LLC.](/funds/1788587.md) | 2026-06-30 | $1.3m | 99,271 | | Reduced −869 | | [Csenge Advisory Group](/funds/1715593.md) | 2026-06-30 | $868.2k | 68,360 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $840.1k | 66,149 | | Added +2,841 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $549.4k | 43,214 | | Reduced −4,719 | | [Baird Financial Group, Inc.](/funds/1648711.md) | 2026-06-30 | $356.1k | 28,041 | | New +28,041 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $289.3k | 22,780 | | Added +148 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $267.0k | 21,024 | | New +21,024 | | [HighTower Advisors, LLC](/funds/1462245.md) | 2026-06-30 | $261.3k | 20,571 | | Unchanged | | [Forum Financial Management, LP](/funds/1911832.md) | 2026-06-30 | $220.0k | 17,321 | | Unchanged | ## Recent filings [All 584 filings](/companies/vhc/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-01 | 12:54 ET | [8-K](/filings/0001140361-26-038170.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-038170 | | 2026-08-14 | 20:06 ET | [10-Q](/filings/0001140361-26-033140.md) | Quarterly report, period 2026-06-30 | 0001140361-26-033140 | | 2026-06-16 | 20:01 ET | [8-K](/filings/0001140361-26-025419.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-26-025419 | | 2026-05-15 | 20:01 ET | [10-Q](/filings/0001140361-26-021650.md) | Quarterly report, period 2026-03-31 | 0001140361-26-021650 | | 2026-04-24 | 20:19 ET | [DEF 14A](/filings/0001140361-26-016717.md) | Proxy statement, period 2026-06-11 | 0001140361-26-016717 | | 2026-03-24 | 20:06 ET | [10-K](/filings/0001140361-26-010895.md) | Annual report, period 2025-12-31 | 0001140361-26-010895 | | 2025-11-26 | 23:34 ET | [SCHEDULE 13D/A](/filings/0001140361-25-043568.md) | Ownership report, active investor, amended | 0001140361-25-043568 | | 2025-11-14 | 21:05 ET | [10-Q](/filings/0001140361-25-042294.md) | Quarterly report, period 2025-09-30 | 0001140361-25-042294 | | 2025-10-17 | 22:40 ET | [8-K](/filings/0001140361-25-038341.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-038341 | | 2025-09-11 | 12:36 ET | [8-K](/filings/0001140361-25-034625.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-034625 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001140361-26-010895.md), filed Mar 24, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/aaed5c1e-aa37-44e4-b9a2-05ea81ed8194) ## About the filer - CIK: 1082324 - Tickers: VHC - Exchange: Nasdaq - SIC code: 6794 Patent Owners & Lessors - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.